Клертис

Клертис (sunitinib cyclamate) is an oral medication used for targeted therapy in oncology. This kinase inhibitor helps manage certain types of cancer by slowing tumor growth. Suitable for patients requiring precision oncology support. Reliable EU-manufactured option for cancer care.

Клертис is used in targeted cancer therapy to slow the progression of certain tumors. It is prescribed for conditions where kinase inhibition can help control disease spread. Patients with gastrointestinal stromal tumors or advanced kidney cancer may benefit from this treatment. Always taken as directed by a healthcare provider.

Common effects may include fatigue, digestive discomfort, or skin changes during treatment. Some patients report mild nausea or changes in taste perception. These effects vary by individual and are typically monitored by medical professionals. Skin reactions, such as rash or dryness, are also possible.

Store Клертис in a cool, dry place away from direct light. Keep the medication out of reach of children and pets. Do not use if the packaging is damaged or the expiry date has passed. Always follow storage instructions provided with the product.

Avoid alcohol while taking Клертис, as it may increase side effects like dizziness. Certain medications, including strong CYP3A4 inhibitors or inducers, can affect how Клертис works. Always inform your doctor about all medications and supplements you are taking.